Cairo – Mubasher: The board of October Pharma has approved the estimated budget for fiscal year (FY) 2021.
The budget aims to achieve sales of EGP 655 million and after-tax net profits of EGP 91.4 million, according to a stock exchange statement on Thursday.
Moreover, the board approved to invest EGP 83.8 million in investment projects in El-Kureimat area and other districts.
In the first nine months of 2020, October Pharma reported a 227.5% annual leap in its net profits, registering EGP 60.6 million.
